Guoping Sun

693 total citations
19 papers, 182 citations indexed

About

Guoping Sun is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guoping Sun has authored 19 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guoping Sun's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and MicroRNA in disease regulation (3 papers). Guoping Sun is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and MicroRNA in disease regulation (3 papers). Guoping Sun collaborates with scholars based in China, United States and Ukraine. Guoping Sun's co-authors include Tao Qin, Yueyin Pan, Hu Liu, Fuxing Xiong, Qi Song, Kangsheng Gu, Zhendong Chen, Geng Song, Hongzhi Wang and Lulu Fan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncotarget.

In The Last Decade

Guoping Sun

16 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoping Sun China 7 90 66 39 27 24 19 182
Carlos Alberto Domínguez-Reyes Mexico 10 120 1.3× 77 1.2× 112 2.9× 22 0.8× 26 1.1× 17 247
Valérie Schuermans Netherlands 6 47 0.5× 42 0.6× 10 0.3× 9 0.3× 36 1.5× 19 155
Paul Cadden United Kingdom 7 72 0.8× 123 1.9× 14 0.4× 29 1.1× 15 0.6× 9 387
Jinyao Shi China 9 42 0.5× 40 0.6× 33 0.8× 8 0.3× 93 3.9× 19 252
Paolo Maietta Spain 8 370 4.1× 47 0.7× 50 1.3× 13 0.5× 20 0.8× 12 448
Baiye Jin China 9 178 2.0× 25 0.4× 85 2.2× 8 0.3× 36 1.5× 21 297
Neng Zhou China 7 98 1.1× 14 0.2× 14 0.4× 8 0.3× 25 1.0× 10 152
Roz Jenkins United Kingdom 7 145 1.6× 62 0.9× 10 0.3× 11 0.4× 50 2.1× 8 334
Jake Cosme Canada 7 133 1.5× 9 0.1× 41 1.1× 17 0.6× 15 0.6× 9 209
Juergen Gindlhuber Austria 9 85 0.9× 10 0.2× 44 1.1× 6 0.2× 16 0.7× 16 195

Countries citing papers authored by Guoping Sun

Since Specialization
Citations

This map shows the geographic impact of Guoping Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Sun more than expected).

Fields of papers citing papers by Guoping Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoping Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Sun. The network helps show where Guoping Sun may publish in the future.

Co-authorship network of co-authors of Guoping Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Guoping Sun. A scholar is included among the top collaborators of Guoping Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoping Sun. Guoping Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
4.
Cheng, Yong, Bin Bao, Tao Meng, et al.. (2024). siRNA-loaded folic acid-modified TPGS alleviate MASH via targeting ER stress sensor XBP1 and reprogramming macrophages. International Journal of Biological Sciences. 20(10). 3823–3841. 3 indexed citations
5.
Li, Dandan, Minglin Ou, Peng Zhu, et al.. (2023). Genotypic Characterization of a Chinese Family with Osteogenesis Imperfecta and Generation of Disease-Specific Induced Pluripotent Stem Cells. Frontiers in Bioscience-Landmark. 28(12). 336–336. 1 indexed citations
6.
Wang, Fang, Yanfeng Zou, Dingtao Hu, et al.. (2020). Overexpression of Rictor protein and Rictor-H. pylori interaction has impact on tumor progression and prognosis in patients with gastric cancer. Folia Histochemica et Cytobiologica. 58(2). 96–107. 5 indexed citations
7.
Sun, Guoping, Dongliang Li, Yifu He, et al.. (2019). Exploration of patients with gastric cancer who benefit from apatinib: An updated real-world study.. Journal of Clinical Oncology. 37(4_suppl). 161–161.
8.
Pan, Zhipeng, Mengya Chen, Xingxing Hu, et al.. (2018). Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on 39 case-control studies. Oncotarget. 9(16). 13068–13076. 18 indexed citations
9.
10.
Liu, Xingcun, et al.. (2017). The diagnostic and prognostic value of serum miR-206 in colorectal cancer.. PubMed. 10(7). 7528–7533. 10 indexed citations
11.
Liu, Jiatao, Lulu Fan, Fang Wang, et al.. (2017). Serum expression and significance of MicroRNA-30d-5p in esophageal squamous cell carcinoma.. PubMed. 10(8). 8677–8685. 7 indexed citations
12.
Liu, Xinyang, Shukui Qin, Zhichao Wang, et al.. (2017). Early presence of antiangiogenesis-related adverse events as a potential biomarker of antitumor efficacy in patients with metastatic gastric cancer treated with apatinib.. Journal of Clinical Oncology. 35(15_suppl). 4052–4052. 1 indexed citations
13.
Huang, Yawei, Guoping Sun, Jiatao Liu, et al.. (2016). miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. OncoTargets and Therapy. 9. 1623–1623. 29 indexed citations
14.
Du, Yingying, et al.. (2016). Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer. Chinese Medical Journal. 129(18). 2168–2172. 4 indexed citations
15.
Fu, Lin, et al.. (2016). Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction. Open Medicine. 11(1). 83–86. 3 indexed citations
16.
Ye, Xiaobing, et al.. (2014). Methylation ofDLEC1Promoter Is a Predictor for Recurrence in Chinese Patients with Gastric Cancer. Disease Markers. 2014. 1–6. 6 indexed citations
17.
18.
Xu, Rui‐Hua, Guoping Sun, Huishan Lu, et al.. (2013). A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma.. Journal of Clinical Oncology. 31(15_suppl). 4025–4025. 10 indexed citations
19.
Qin, Tao, Hu Liu, Qi Song, et al.. (2010). The Screening of Volatile Markers for Hepatocellular Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 19(9). 2247–2253. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Alberto Domínguez-Reyes Breakdown of academic impact, for papers by Valérie Schuermans Breakdown of academic impact, for papers by Paul Cadden Breakdown of academic impact, for papers by Jinyao Shi Breakdown of academic impact, for papers by Paolo Maietta Breakdown of academic impact, for papers by Baiye Jin Breakdown of academic impact, for papers by Neng Zhou Breakdown of academic impact, for papers by Roz Jenkins Breakdown of academic impact, for papers by Jake Cosme Breakdown of academic impact, for papers by Juergen Gindlhuber
Rankless by CCL
2026